Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Aplan

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Plos One|September 28, 2017
Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndromeYang Jo Chung, Terry J Fry, Peter D Aplan
Neoplasia (New York, N.Y.)|April 27, 2007
Cre-loxP-mediated recombination between the SIL and SCL genes leads to a block in T-cell development at the CD4- CD8- to CD4+ CD8+ transitionYue Cheng, Zhenhua Zhang, Christopher Slape, et al.
Plos One|May 19, 2012
Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effectSheryl M Gough, Yang Jo Chung, Peter D Aplan
Blood|June 9, 2016
Therapeutic targeting of IL-7Rα signaling pathways in ALL treatmentSarah D Cramer, Peter D Aplan, Scott K Durum
Seminars in Hematology|December 14, 2024
A Call to Arms: Overcoming challenges in Myelodysplastic Syndromes therapy advancesKathy L McGraw, Peter D Aplan, Steven Z Pavletic
Blood|September 28, 2011
NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insightsSheryl M Gough, Christopher I Slape, Peter D Aplan
Blood|April 22, 2004
NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutationRhonna M Gurevich, Peter D Aplan, R Keith Humphries
Cancer Research|September 7, 2007
Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic miceDavid Caudell, Zhenhua Zhang, Yang Jo Chung, et al.
Blood|June 21, 2008
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and CblChristopher Slape, Leah Y Liu, Sarah Beachy, et al.
Blood|March 10, 2005
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemiaYing-Wei Lin, Christopher Slape, Zhenhua Zhang, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Plos One|September 28, 2017
Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndromeYang Jo Chung, Terry J Fry, Peter D Aplan
Neoplasia (New York, N.Y.)|April 27, 2007
Cre-loxP-mediated recombination between the SIL and SCL genes leads to a block in T-cell development at the CD4- CD8- to CD4+ CD8+ transitionYue Cheng, Zhenhua Zhang, Christopher Slape, et al.
Plos One|May 19, 2012
Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effectSheryl M Gough, Yang Jo Chung, Peter D Aplan
Blood|June 9, 2016
Therapeutic targeting of IL-7Rα signaling pathways in ALL treatmentSarah D Cramer, Peter D Aplan, Scott K Durum
Seminars in Hematology|December 14, 2024
A Call to Arms: Overcoming challenges in Myelodysplastic Syndromes therapy advancesKathy L McGraw, Peter D Aplan, Steven Z Pavletic
Blood|September 28, 2011
NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insightsSheryl M Gough, Christopher I Slape, Peter D Aplan
Blood|April 22, 2004
NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutationRhonna M Gurevich, Peter D Aplan, R Keith Humphries
Cancer Research|September 7, 2007
Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic miceDavid Caudell, Zhenhua Zhang, Yang Jo Chung, et al.
Blood|June 21, 2008
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and CblChristopher Slape, Leah Y Liu, Sarah Beachy, et al.
Blood|March 10, 2005
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemiaYing-Wei Lin, Christopher Slape, Zhenhua Zhang, et al.
Pageof 11